-
Je něco špatně v tomto záznamu ?
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation
K. Spilovska, J. Korabecny, V. Sepsova, D. Jun, M. Hrabinova, P. Jost, L. Muckova, O. Soukup, J. Janockova, T. Kucera, R. Dolezal, E. Mezeiova, D. Kaping, K. Kuca,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- acetylcholinesterasa metabolismus MeSH
- aktivace enzymů účinky léků MeSH
- Alzheimerova nemoc enzymologie MeSH
- apigenin chemie MeSH
- butyrylcholinesterasa metabolismus MeSH
- cholinesterasové inhibitory chemická syntéza chemie farmakologie MeSH
- glukuronáty chemie MeSH
- hematoencefalická bariéra metabolismus MeSH
- lidé MeSH
- racionální návrh léčiv MeSH
- simulace molekulového dockingu MeSH
- takrin analogy a deriváty chemie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
A novel series of 6-chlorotacrine-scutellarin hybrids was designed, synthesized and the biological activity as potential anti-Alzheimer's agents was assessed. Their inhibitory activity towards human acetylcholinesterase (hAChE) and human butyrylcholinesterase (hBChE), antioxidant activity, ability to cross the blood-brain barrier (BBB) and hepatotoxic profile were evaluated in vitro. Among these compounds, hybridK1383, bearing two methylene tether between two basic scaffolds, was found to be very potenthAChE inhibitor (IC50= 1.63 nM). Unfortunately, none of the hybrids displayed any antioxidant activity (EC50≥ 500 μM). Preliminary data also suggests a comparable hepatotoxic profile with 6-Cl-THA (established on a HepG2 cell line). Kinetic studies performed onhAChE with the most active compound in the study,K1383, pointed out to a mixed, non-competitive enzyme inhibition. These findings were further corroborated by docking studies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010482
- 003
- CZ-PrNML
- 005
- 20180404142049.0
- 007
- ta
- 008
- 180404s2017 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules22061006 $2 doi
- 035 __
- $a (PubMed)28621747
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Spilovska, Katarina $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. k.spilovska@gmail.com. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. k.spilovska@gmail.com.
- 245 10
- $a Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation / $c K. Spilovska, J. Korabecny, V. Sepsova, D. Jun, M. Hrabinova, P. Jost, L. Muckova, O. Soukup, J. Janockova, T. Kucera, R. Dolezal, E. Mezeiova, D. Kaping, K. Kuca,
- 520 9_
- $a A novel series of 6-chlorotacrine-scutellarin hybrids was designed, synthesized and the biological activity as potential anti-Alzheimer's agents was assessed. Their inhibitory activity towards human acetylcholinesterase (hAChE) and human butyrylcholinesterase (hBChE), antioxidant activity, ability to cross the blood-brain barrier (BBB) and hepatotoxic profile were evaluated in vitro. Among these compounds, hybridK1383, bearing two methylene tether between two basic scaffolds, was found to be very potenthAChE inhibitor (IC50= 1.63 nM). Unfortunately, none of the hybrids displayed any antioxidant activity (EC50≥ 500 μM). Preliminary data also suggests a comparable hepatotoxic profile with 6-Cl-THA (established on a HepG2 cell line). Kinetic studies performed onhAChE with the most active compound in the study,K1383, pointed out to a mixed, non-competitive enzyme inhibition. These findings were further corroborated by docking studies.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a Alzheimerova nemoc $x enzymologie $7 D000544
- 650 _2
- $a apigenin $x chemie $7 D047310
- 650 _2
- $a hematoencefalická bariéra $x metabolismus $7 D001812
- 650 _2
- $a butyrylcholinesterasa $x metabolismus $7 D002091
- 650 _2
- $a cholinesterasové inhibitory $x chemická syntéza $x chemie $x farmakologie $7 D002800
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a aktivace enzymů $x účinky léků $7 D004789
- 650 _2
- $a glukuronáty $x chemie $7 D005965
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a takrin $x analogy a deriváty $x chemie $7 D013619
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Korabecny, Jan $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. korabecny.jan@gmail.com. Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. korabecny.jan@gmail.com.
- 700 1_
- $a Sepsova, Vendula $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. vsepsova@gmail.com. Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. vsepsova@gmail.com.
- 700 1_
- $a Jun, Daniel $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. daniel.jun@unob.cz. Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. daniel.jun@unob.cz.
- 700 1_
- $a Hrabinova, Martina $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. martina.hrabinova@unob.cz. Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. martina.hrabinova@unob.cz.
- 700 1_
- $a Jost, Petr $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. petr.jost@unob.cz.
- 700 1_
- $a Muckova, Lubica $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. lubica.muckova@unob.cz.
- 700 1_
- $a Soukup, Ondrej $u National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. ondrej.soukup@fnhk.cz. Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz.
- 700 1_
- $a Janockova, Jana $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. jana.janockova@gmail.com.
- 700 1_
- $a Kucera, Tomas $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Tomas.kucera2@unob.cz.
- 700 1_
- $a Dolezal, Rafael $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. rafael.dolezal@centrum.cz.
- 700 1_
- $a Mezeiova, Eva $u National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. eva.mezeiova@gmail.com. Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. eva.mezeiova@gmail.com.
- 700 1_
- $a Kaping, Daniel $u National Institute of Mental Health, Topolova 748, 250 67 Klecany, Czech Republic. Daniel.Kaping@nudz.cz.
- 700 1_
- $a Kuca, Kamil $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. kamil.kuca@fnhk.cz.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 22, č. 6 (2017)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28621747 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142129 $b ABA008
- 999 __
- $a ok $b bmc $g 1287967 $s 1007294
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 22 $c 6 $e 20170616 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20180404